COVID-19
Showing NaN - NaN of 65
COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)
Recruiting
- COVID-19
- mRNA-1283.222
- mRNA-1273.222
-
Birmingham, Alabama
- +209 more
Apr 13, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)
Completed
- COVID-19
- LY3819253
- +2 more
-
Tucson, Arizona
- +56 more
Mar 22, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
COVID-19 Trial in Boston (vitamin D, Placebo)
Active, not recruiting
- COVID-19
- vitamin D
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 25, 2023
Atrial Fibrillation, COVID-19, Cancer Trial in Boston (drug, device, procedure)
Recruiting
- Atrial Fibrillation
- +3 more
- [64Cu]FBP8
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Dec 20, 2022
COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)
Completed
- COVID-19
- +2 more
- pathogen reduced SARS-CoV-2 convalescent plasma
- Placebo
-
Little Rock, Arkansas
- +25 more
Oct 6, 2022
Infection Viral, Thromboses, Venous, COVID-19 Trial in United States (Enoxaparin Prefilled Syringe [Lovenox])
Completed
- Infection Viral
- +2 more
- Enoxaparin Prefilled Syringe [Lovenox]
-
Birmingham, Alabama
- +15 more
Sep 15, 2022
COVID-19, Stress, Shortness of Breath Trial in Boston (Breathing and Wellness Webinar, Routine Daily Activity)
Enrolling by invitation
- COVID-19
- +2 more
- Breathing and Wellness Webinar
- Routine Daily Activity
-
Boston, MassachusettsBeth Israel Deaconess Medical Centre
Oct 6, 2022
SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19
Completed
- SARS-CoV Infection
- +3 more
- Moderna COVID-19 Vaccine
- +2 more
-
Tucson, Arizona
- +28 more
Sep 19, 2022
COVID-19 Trial in United States (Lopinavir/Ritonavir 400 mg/100 mg, Placebo)
Active, not recruiting
- COVID-19
- Lopinavir/Ritonavir 400 mg/100 mg
- Placebo
-
Aurora, Colorado
- +5 more
Aug 17, 2022
Acute Respiratory Distress Syndrome, COVID-19 Trial in United States (Brexanolone, Placebo)
Terminated
- Acute Respiratory Distress Syndrome
- COVID-19
- Brexanolone
- Placebo
-
Fresno, California
- +8 more
Aug 17, 2022
COVID-19, SARS-CoV-2 Trial in United States (Ascorbic Acid, Hydroxychloroquine Sulfate, Azithromycin)
Terminated
- COVID-19
- SARS-CoV-2
- Ascorbic Acid
- +4 more
-
Chicago, Illinois
- +5 more
Jul 12, 2022
COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)
Completed
- COVID-19
- Lenzilumab
- +2 more
-
Birmingham, Alabama
- +55 more
Jul 21, 2022
COVID-19, COVID Trial in Boston (Pegylated interferon lambda)
Terminated
- COVID-19
- COVID
- Pegylated interferon lambda
-
Boston, MassachusettsMassachusetts General Hospital
Jun 29, 2022
COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
-
Phoenix, Arizona
- +83 more
Jul 13, 2022